The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma

<div class="floats-full-page floats-full-page-figure"><h2>Figure 1</h2><div class="floats-full-page-caption"><div>The FDG-PET/CT scan at relapse showed a huge tumor mass with high metabolic rate.</div></div><div class="floats-full-page-content"><table class="figure-group"><tr class="fig-image"><td><object data="https://static-01.hindawi.com/articles/crihem/volume-2019/2845130/figures/2845130.fig.001.svgz" name="2845130.fig.001" type="image/svg+xml"></object></td></tr></table></div></div>

Figure 1 | The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma

title

Figure 1: The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma

description

Figure 1

About this journal

<p><em>Case Reports in Hematology</em> publishes case reports and case series in all areas of hematology, including general hematology, pathology, and oncology, with a specific focus on lymphomas and leukemias.</p>


Journal profile

Meet the editorial board

<p><em>Case Reports in Hematology</em> maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.</p>


Editor spotlight

Find out more

This journal's articles appear in a wide range of abstracting and indexing databases, and are covered by numerous other services that aid discovery and access. Find out more about where and how the content of this journal is available.